BackAmexdrug Overview

Amexdrug Total Current Liabilities

Track Amexdrug's total current liabilities ($160K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$156742.00
↓ 35.71% YoYΔ $-87076.00 vs prior year quarter

Peer trimmed avg / median

Loading

Amexdrug Total Current Liabilities History

Loading

Amexdrug vs. peers: Total Current Liabilities Comparison

Loading

Amexdrug Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amexdrug (AXRX) FAQ

Amexdrug (AXRX) currently reports a total current liabilities of $160K as of March 2026. That compares with $240K in the prior-year period — down 35.7% year over year. Use the charts on this page to explore Amexdrug's total current liabilities history and peer comparisons.

Amexdrug's total current liabilities decreased from $240K to $160K — a 35.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amexdrug reported $160K in total current liabilities as of March 2026. That compares with $240K in the prior-year period — down 35.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $160K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amexdrug, and consider following AXRX for alerts when major investors trade the stock.